Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T‐cell leukemia
European Journal of Haematology · 2024
DOI: 10.1111/ejh.14209 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Chie Ishikawa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Oncology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan. Hauptthemen laut MEDLINE: Dihydroorotate Dehydrogenase, Leukemia-Lymphoma, Adult T-Cell, Oxidoreductases Acting on CH-CH Group Donors, Cell Proliferation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Objectives
We aimed to determine the role of dihydroorotate dehydrogenase (DHODH) in pathogenesis of adult T‐cell leukemia (ATL) caused by human T‐cell leukemia virus type 1 (HTLV‐1) and the effects of its inhibition on the de novo pyrimidine biosynthesis pathway.
Methods
Cell proliferation, viability, cycle, and apoptosis were analyzed using WST‐8 assays, flow cytometry, and Hoechst 33342 staining. To elucidate the molecular mechanisms involved in the anti‐ATL effects of DHODH knockdown and inhibition, RT‐PCR and immunoblotting were conducted.
Results
HTLV‐1‐infected T‐cell lines aberrantly expressed DHODH. Viral infection and the oncoprotein, Tax, enhanced DHODH expression, while knockdown of DHODH decreased HTLV‐1‐infected T‐cell growth. In addition, BAY2402234, a DHODH inhibitor, exerted an anti‐proliferative effect, which was reversed by uridine supplementation. BAY2402234 induced DNA damage and S phase arrest by downregulating c‐Myc, CDK2, and cyclin A and upregulating p53 and cyclin E. It also induced caspase‐mediated apoptosis by the upregulation of pro‐apoptotic and downregulation of anti‐apoptotic proteins. Furthermore, BAY2402234 induced caspase‐independent ferroptosis and necroptosis. It decreased phosphorylation of IKK, IκBα, PTEN, Akt, and its downstream targets, suggesting that inhibition of NF‐κB and Akt signaling is involved in its anti‐ATL action.
Conclusion
These findings highlight DHODH as a potential therapeutic target for treating ATL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Oncology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.
- Division of Health Sciences, Transdisciplinary Research Organization for Subtropics and Island Studies, University of the Ryukyus, Nishihara, Japan.
ORCID-Profile: Naoki Mori
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Ishikawa, C., & Mori, N. (2024). Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T‐cell leukemia. European Journal of Haematology. https://doi.org/10.1111/ejh.14209
Vancouver
Ishikawa C, Mori N. Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T‐cell leukemia. European Journal of Haematology. 2024. doi:10.1111/ejh.14209
BibTeX
@article{Ishikawa2024,
author = {Ishikawa, Chie and Mori, Naoki},
title = {Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T‐cell leukemia},
journal = {European Journal of Haematology},
year = {2024},
doi = {10.1111/ejh.14209}
}
EUVIMED